Search

Displaying results 4711 - 4720 of 10000 in total
  1. Drug

    Fostedil

    go.drugbank.com/drugs/DB20574
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Fostedil is a vasodilator. Fostedil has a monoisotopic molecular weight of 361.09 Da.

  2. Drug

    Stevaladil

    go.drugbank.com/drugs/DB20689
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Stevaladil is a vasodilator. Stevaladil has a monoisotopic molecular weight of 447.33 Da.

  3. Drug

    Meluadrine

    go.drugbank.com/drugs/DB20693
    Experimental

    The usage of the INN stem '-drine' in the name indicates that Meluadrine is a sympathomimetic. Meluadrine has a monoisotopic molecular weight of 243.1 Da.

  4. Drug

    Bamirastine

    go.drugbank.com/drugs/DB21186
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Bamirastine is a antihistaminic. Bamirastine has a monoisotopic molecular weight of 527.29 Da.

  5. Drug

    Barmastine

    go.drugbank.com/drugs/DB21253
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.

  6. Drug

    Zanoterone

    go.drugbank.com/drugs/DB21384
    Experimental

    The usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.

  7. Indication

    Venous Hypertension Ulcers

    go.drugbank.com/conditions/DBCOND0079472
    Drugs: Balsam of Peru · Hyaluronic acid
    Synonyms: Skin ulcer NOS, Venous ulcer NOS
  8. Indication

    Venous Leg Ulcers (VLU)

    go.drugbank.com/conditions/DBCOND0147916
    Drugs: Pentoxifylline · Sulodexide
    Synonyms: Venous ulcer NOS, Skin ulcer NOS
  9. Drug

    Atacicept

    go.drugbank.com/drugs/DB06399
    ApprovedInvestigational

    Atacicept is a recombinant fusion glycoprotein that joins the ligand-binding portion of the human TACI receptor to a modified IgG1 Fc domain, allowing it to bind and neutralize two cytokines: B cell activating factor (BAFF) and A Prolife...

  10. Drug

    Romidepsin

    go.drugbank.com/drugs/DB06176
    ApprovedInvestigational

    Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.